SPL-2992

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSPL-2992
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsLiver NeoplasmsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStarpharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStarpharma Pty Ltd
Active IndicationsN/A
Inactive IndicationsLiver NeoplasmsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A